166941-47-5 Usage
Description
(S)-(-)-2-T-BUTYL-2-PIPERAZINECARBOXAMIDE, a chemical compound with the molecular formula C11H22N2O and a molecular weight of 198.31 g/mol, is classified under chiral building blocks, piperazines, and pharmaceutical intermediates. It exhibits optical rotation of -46 (c=1, MeOH) and is primarily utilized in the pharmaceutical industry. Its exact applications are still under research and exploration.
Uses
Used in Pharmaceutical Industry:
(S)-(-)-2-T-BUTYL-2-PIPERAZINECARBOXAMIDE is used as a pharmaceutical intermediate for the development of new drugs and medications. Its role in this industry is to serve as a building block in the synthesis of various pharmaceutical compounds, contributing to the creation of potential therapeutic agents.
It is important to handle and store (S)-(-)-2-T-BUTYL-2-PIPERAZINECARBOXAMIDE appropriately in laboratory or industrial settings to maintain its stability and prevent any potential danger or dysfunction. As research progresses, further applications and uses of this compound may be discovered, expanding its utility in the pharmaceutical field and potentially other industries.
Check Digit Verification of cas no
The CAS Registry Mumber 166941-47-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,6,9,4 and 1 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 166941-47:
(8*1)+(7*6)+(6*6)+(5*9)+(4*4)+(3*1)+(2*4)+(1*7)=165
165 % 10 = 5
So 166941-47-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H19N3O/c1-8(2,3)9(7(10)13)6-11-4-5-12-9/h11-12H,4-6H2,1-3H3,(H2,10,13)/t9-/m0/s1
166941-47-5Relevant articles and documents
Process for the preparation of optically active piperazine-2-carboxylic acid derivatives
-
, (2008/06/13)
Optically active piperazine-2-carboxylic acid derivatives of the general formula: STR1 in which X is alkoxy or a (substituted) amino group, are prepared by asymmetric hydrogenation of the corresponding pyrazinecarboxylic acid derivatives, catalyzed by optically active rhodium complexes. The compounds of the formula I are intermediates for the preparation of pharmaceutical active substances, for example, HIV protease inhibitors.